EC
Euclidean Capital Portfolio holdings
AUM
$306M
This Quarter Return
-3.16%
1 Year Return
+16.69%
3 Year Return
+17.66%
5 Year Return
–
10 Year Return
–
AUM
$108M
AUM Growth
+$108M
(-8.4%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 96.6% |
| 2 | Financials | 3.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ME
1
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $29.3M | 27.2% |
10,243,122
| – | – |
|
2
PMV Pharmaceuticals
PMVP
$74.2M
| $27.8M | 25.82% |
2,336,909
| – | – |
|
3
Foghorn Therapeutics
FHTX
$286M
| $10.8M | 10.05% |
1,261,261
| – | – |
|
4
RAPT Therapeutics
RAPT
$196M
| $10.4M | 9.67% |
432,900
| – | – |
|
|
NGM
5
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $9.77M | 9.07% |
746,674
| – | – |
|
6
Alector
ALEC
$262M
| $9.28M | 8.61% |
980,894
| – | – |
|
7
First Financial Bancorp
FFBC
$2.51B
| $3.66M | 3.4% |
173,576
| – | – |
|
8
Tenaya Therapeutics
TNYA
$176M
| $2.66M | 2.47% |
915,705
| – | – |
|
9
Oric Pharmaceuticals
ORIC
$994M
| $2.39M | 2.22% |
747,550
| – | – |
|
10
Surrozen
SRZN
$104M
| $1.62M | 1.51% |
802,963
| – | – |
|